Enhanced invasiveness of drug‐resistant acute myeloid leukemia cells through increased expression of matrix metalloproteinase‐2
Open Access
- 23 February 2009
- journal article
- research article
- Published by Wiley in International Journal of Cancer
- Vol. 125 (5), 1074-1081
- https://doi.org/10.1002/ijc.24386
Abstract
The acquired drug resistance as well as extramedullary tissue infiltration of leukemic cells is a major obstacle in leukemia treatment. Excessive egress of leukemia cell blasts results in invasion into various organs or tissues, which is facilitated by the catalytic activities of matrix metalloproteinases (MMPs). However, the migration of chemoresistant leukemia cells remains unclear. Here, we generated drug‐resistant variants of the human acute myeloid leukemia cell line (AML‐2/WT) by stepwise exposure to anticancer drugs and evaluated the level of MMP‐2 in the drug‐resistant variants, along with their invasiveness. Each of the drug‐resistant cell variants demonstrated predominant increases in the expression and gelatinolytic activity of MMP‐2 as well as in invasiveness, which were significantly suppressed by both a MMP‐2 inhibitor and a blocking antibody. Knockdown experiments using MMP‐2 short hairpin RNA also indicated that its upregulation was strongly associated with the cells' increased invasive properties. Importantly, elevated levels of MMP‐2 activity and invasiveness were observed in ex vivo mononuclear cell of bone marrow from patients with poor responses to chemotherapy. These findings suggest that advanced malignancy due to acquired drug resistance is responsible for the progressive invasiveness of leukemia cells via MMP‐2. © 2009 UICCKeywords
This publication has 29 references indexed in Scilit:
- Expression of matrix metalloproteinase (MMP) and tissue inhibitor of MMP (TIMP) genes in blasts of infant acute lymphoblastic leukemia with organ involvementLeukemia Research, 2007
- Cell-surface association between matrix metalloproteinases and integrins: role of the complexes in leukocyte migration and cancer progressionBlood, 2006
- Matrix metalloproteinases and tumor metastasisCancer and Metastasis Reviews, 2006
- Hurdles to Lymphocyte Trafficking in the Tumor Microenvironment: Implications for Effective ImmunotherapyImmunological Investigations, 2006
- Enhanced in vitro invasiveness and drug resistance with altered gene expression patterns in a human lung carcinoma cell line after pulse selection with anticancer drugsInternational Journal of Cancer, 2004
- The possible role of matrix metalloproteinase (MMP)-2 and MMP-9 in cancer, e.g. acute leukemiaCritical Reviews in Oncology/Hematology, 2004
- Novel mechanistic concepts for the control of leukocyte transmigration: specialization of integrins, chemokines, and junctional moleculesJournal of Molecular Medicine, 2003
- Human T-cell leukemia virus type I Tax transactivates the matrix metalloproteinase-9 gene: potential role in mediating adult T-cell leukemia invasivenessBlood, 2002
- Relationship between the intracellular daunorubicin concentration, expression of major vault protein/lung resistance protein and resistance to anthracyclines in childhood acute lymphoblastic leukemiaLeukemia, 1999
- Matrix Metalloproteinases in the Hematopoietic MicroenvironmentHematology, 1999